Bosentan for the Prevention of Overcirculation-Induced Experimental Pulmonary Arterial Hypertension

Abstract
Background— The dual endothelin-receptor antagonist bosentan has been reported to improve pulmonary arterial hypertension, but the role of endothelins in the pathogenesis of the condition remains u...

This publication has 21 references indexed in Scilit: